Pirtobrutinib Improves PFS in Treatment-Naive CLL/SLL



The noncovalent BTKi shows highly favorable progression-free survival in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/pirtobrutinib-improves-pfs-treatment-naive-cll-sll-2025a1000zaq?src=rss

Author :

Publish date : 2025-12-16 13:25:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version